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Abstract 
The consensus pentapeptide GXSXG is found in virtually all lipases/esterases and generally contains the active site serine. The primary sequence 
of hormone-sensitive lipase contains a single copy of this pentapeptide, surrounding Ser-423. We have analyzed the catalytic role of Ser-423 by 
site-directed mutagenesis and expression of the mutant hormone-sensitive lipase in COS cells. Substitution of Ser-423 by several different amino acids 
resulted in the complete abolition of both lipase and esterase activity, whereas mutation of other conserved serine residues had no effect on the catalytic 
activity. These results strongly suggest that Ser-423 is the active site serine of hormone-sensitive lipase. 
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1. Introduction 
Hormone-sensitive lipase (HSL; EC 3.1.1.3.) catalyzes 
the rate-limiting step in the hydrolysis of stored tria- 
cylglycerols and is therefore a key enzyme in lipid metab- 
olism and overall energy homeostasis [ 1,2]. Its activity is 
under acute neural and hormonal control, exerted via 
phosphorylation of a single serine residue (Ser-563 in rat 
HSL) by CAMP-dependent protein kinase [3,4]. Lipolytic 
hormones, such as catecholamines, cause a phosphoryla- 
tion and concomitant activation of HSL, whereas anti- 
lipolytic hormones, of which insulin is the most impor- 
tant, cause a net dephosphorylation and deactivation of 
HSL. 
HSL in the rat is a protein of 768 amino acids, which 
shows no significant overall homology with any of the 
other sequenced mammalian lipases [3,.5]. In particular, 
it shares no obvious sequence homology with the mem- 
bers of the lipase gene family, i.e. pancreatic lipase, lipo- 
protein lipase and hepatic lipase. However, HSL has 
several biochemical and functional features in common 
with these lipases. For instance, both HSL and lipopro- 
tein lipase hydrolyze long-chain triacylglycerols, have 
similar positional specificity, are inhibited by serine-di- 
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Abbreviations: cDNA, complementary DNA; DFP, diisopropyl fluoro- 
phosphate; HSL, hormone-sensitive lipase; PBS, phosphate-buffered 
saline; PCR, polymerase chain reaction; SDS-PAGE, polyacrylamide 
gel elecrophoresis in sodium dodecyl sulphate. 
rected reagents and most likely function as dimers [ 1,2,6]. 
On the other hand, HSL has some unique features. The 
most noticeable is its dramatic activation upon phospho- 
rylation by CAMP-dependent protein kinase, and its abil- 
ity to hydrolyze cholesteryl esters [1,2]. Moreover, it has 
been shown that HSL shows a relatively higher catalytic 
activity at low temperatures than both lipoprotein lipase 
[6] and carboxyl ester lipase [7]. This property was dis- 
covered after an unexpected homology between HSL 
and lipase 2 of Moraxella TA 144, an antarctic, psychro- 
trophic bacterium, had been found [5,8]. It may reflect 
a cold-adaptability property of HSL [5] and could be of 
vital importance in hibernators and poikilotherms. The 
sequence relationship found between HSL and the Mo- 
raxella lipase was recently extended to include several 
other bacterial proteins from distantly related eubacteria 
[9,10], and it was suggested that HSL is closely related 
to a group of bacterial proteins, and only very distantly 
related to lipoprotein lipase, hepatic lipase and pancre- 
atic lipase [lo]. 
In common with virtually all other hitherto sequenced 
mammalian and microbial lipases and esterases [I 1,121, 
HSL contains a GXSXG motif, in this case surrounding 
Ser-423 [3,5]. Site-directed mutagenesis has been used to 
show that the pentapeptide serine is analogous to the 
active site serine in several lipases, including hepatic li- 
pase, lipoprotein lipase and pancreatic lipase [13-171. 
Structural evidence for the catalytic site serine of these 
related lipases was obtained upon determination of the 
crystal structure of pancreatic lipase, which revealed that 
the serine of this motif is part of a catalytic triad also 
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including an aspartic acid and a histidine [18]. However, 
the GXSXG motif has a wide occurrence and is found 
in approximately every tenth protein in the existing data- 
bases, including many proteins with no hydrolytic func- 
tion [12]. This fact, together with the observation that 
HSL seems to be closely related to some not very well- 
characterized bacterial proteins rather than to the mam- 
malian lipases, where the GXSXG is known to contain 
the active site serine, prompted us to investigate the func- 
tional role of Ser-423. 
We have used site-directed mutagenesis to produce 
mutants with conservative substitutions for Ser-423. In 
addition, other serine residues, randomly picked, but 
conserved between rat and human HSL, were mutated 
to serve as controls. Activities of the resulting mutants 
are consistent with the conclusion that Ser-423 is the 
catalytic serine in HSL. 
2. Materials and methods 
2.1. Construction of mutants 
Mutations were introduced into rat HSL cDNA using the PCR 
overlap extension method [19] and Vent DNA polymerase with proof- 
reading activity (New England Biolabs.) to amplify sequences from 
full-length rat HSL cDNA in the pSVL vector [20]. Briefly, each mutant 
construct was composed of two PCR fragments, joined at the site of 
the mutation, and together encompassing the complete rat HSL coding 
sequence. Primers for the C-terminal fragment consisted of a 27-mer 
containing the desired mutation as its central codon and a 27-mer 
containing the reverse complement of the cDNA 8 nucleotides down- 
stream of the stop codon. Similarly, the N-terminal fragment was 
flanked by primers beginning at the ATG start codon and ending with 
reverse complement of the mutant oligo described above. The two PCR 
fragments were purified by Centricon 100 (Amicon), separated from the 
template by agarose gel-electrophoresis and joined in a final PCR reac- 
tion using overlap extension. The final product was purified by Centri- 
con 100, digested with XhoI and Sac1 (sites for these enzymes were 
included in the end primers), isolated by agarose gel-electrophoresis 
and then ligated into pSVL. A cDNA without mutations was also 
constructed using Vent DNA polymerase and the same cDNA template 
and end primers as above. This was ligated into pSVL and used as 
control DNA in the transfection experiments (referred to as wild-type 
DNA). 
2.2. DNA sequencing 
The identity of each mutant and the absence of PCR mistakes in the 
inactive HSL Ser-423 mutants was confirmed by dideoxynucleotide 
sequencing of double-stranded DNA using the Taq Dyedoxy termina- 
tor cycle sequencing kit (Applied Biosystems) and a model 373A DNA 
sequencer (Applied Biosystems). Besides the introduced mutations, 
some differences from the reported cDNA sequence [3] were observed 
in all mutants, and also in the wild-type DNA (see above). First of all, 
as detected previously (Z. Li, M. Sumida, A. Birchbauer, M.C. Schotz 
and K. Reue, personal communication), at position 2850 [21] an extra 
C was found, which changes and extends the C-terminal region of the 
deduced amino acid sequence from GRPRSCACSASG to 
RQAAELCVQRIRLILTPPAAPLT. Secondly, in the sequence coding 
for the region immediately upstream of the phosphorylation sites, 
which is predicted to be a connecting loop in the rat protein but is 
absent in the human protein [5], a reported G at position 2239 [21] could 
not be confirmed, and at position 2281 [21] an extra C was found. This 
changes the deduced amino acid sequence in the region from amino 
acids 542-556 from VACNRDTAPHGFWAL to LPATETPRPTDS- 
GRL. The observed differences from the reported cDNA sequence 
[3,21] have been confirmed by re-sequencing the original cDNA clones 
from the 1gtll library [3,21] subcloned into pUC19. 
2.3. Transfection and expression of HSL cDNA 
Transfection of COS cells by lipofectin (BRL) was performed as 
previously described using 1 pug of DNA per 60 mm dish [20]. Cells were 
harvested after 72 h by centrifugation in PBS, followed by homogeniza- 
tion in 0.25 M sucrose, 1 mM EDTA, 1 mM dithioerythritol, 20 &ml 
leupeptin, 2 pg/ml antipain and 1 pg/ml pepstatin at 4°C. Total protein 
in the cell homogenates was measured according to Bradford [22] using 
bovine serum albumin as the standard. 
2.4. Western blot analysis 
The HSL protein concentration in the cell homogenates was esti- 
mated by subjecting aliquots of the different homogenates to SDS- 
PAGE, followed by Western blot analysis using a polyclonal HSL 
antibody, anti-rabbit IgG, conjugated to alkaline phosphatase, and a 
chromogenic substrate (Protoblot II AP Systems; Promega, Madison, 
WI) [23,24]. 
2.5. HSL assay 
The lipase activity of homogenized cells was measured using a phos- 
pholipid-stabilized emulsion of 1 (3)-mono [3H]oleoyl-2-oleylglycerol, 
a diacylglycerol ether analogue [25]. HSL activity is expressed in mU 
where 1 mU = 1 nmol fatty acid released per min at 37°C. 
2.6. Esterase assay 
Activity toward water-soluble substrate was measured usingp-nitro- 
phenylbutyrate [26]. Briefly, aliquots of the homogenized cells were 
incubated in 1 ml of 0.1 M NaH,PO,, 0.9% NaCl, 1 mM dithioerythritol 
and 0.5 mM p-nitrophenylbutyrate for 10 min at 37°C. Enzyme reac- 
tions were terminated by the addition of 3.25 ml methanol/chloroform/ 
heptane (10:9:7) to form a two-phase partition system. Absorbance of 
the p-nitrophenol-containing supernatant was measured at 400 nm. 
3. Results and discussion 
The serine of the GXSXG motif in rat HSL, i.e. Ser- 
423, was mutated to either Gly, Ala, Thr or Cys (Table 
1). These substitutions for serine have been shown to 
minimize disturbance in protein structure [27]. Four 
other serine residues, randomly picked but conserved 
between the rat and human sequence [3,5], were also 
mutated (Table 1). The different HSL cDNAs were sub- 
cloned in pSVL and expressed in COS cells. Homoge- 
nates of harvested cells were analyzed for expression of 
HSL protein by Western blot analysis with an anti-rat 
HSL antibody. All the different mutants were shown to 
be expressed to approximately the same level as wild- 
type HSL (Fig. 1). 
The lipase activity of the different mutants were meas- 
ured in the cell homogenates using a diacylglycerol ana- 
Table 1 
Site-specific mutations in HSL 
Plasmid Amino acid Resultant 
amino acid 
pSVL/423-SG 
pSVLi423-SA 
pSVLi423-SC 
pSVLl423ST 
pSVLll&SA 
pSVIi320-SA 
pSVLl412-SA 
pSVL/533-SA 
Ser-423 
Ser-423 
Ser-423 
Ser-423 
Ser-185 
Ser-320 
Ser-412 
Ser-533 
GUY 
Ala 
Cys 
Thr 
Ala 
Ala 
Ala 
Ala 
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kDa 
180- 
116- 
84- 
58- 
48- 
36- 
B 
kDa 
180- 
116- 
84- 
58- 
48- 
36- 
Fig. 1. Expression of HSL mutants in COS cells. (A) pSVL plasmids 
containing HSL cDNAs encoding mutations of Ser-423 to Gly, Ala, 
Cys or Thr, and (B) pSVL plasmids containing HSL cDNAs encoding 
mutations of Ser-185 to Ala, Ser-320 to Ala, Ser-412 to Ala and Ser-533 
to Ala, Gly, Cys or Thr, were used to transfect COS cells. Aliquots of 
the cell homogenates, corresponding to equal amounts of total protein, 
were analyzed by SDS-PAGE and Western blot analysis, as described 
in section 2. The different mutations are denoted as follows: SG, 
glycine; SA, alanine; SC, cysteine; ST, threonine. W.T.HSL, wild-type 
HSL; pSVL, the pSVL vector alone without HSL cDNA. 
log as substrate. None of the Ser-423 mutants had any 
significant lipase activity above that of cells transfected 
with the pSVL vector alone (Fig. 2A) whereas the activ- 
ities of other serine mutants were not significantly differ- 
ent from the wild-type HSL (Fig. 3). 
To distinguish between an effect due to a mutation in 
the catalytic site from a mutation in the interfacial bind- 
ing site, esterase activity measurements were performed 
against p-nitrophenylbutyrate. This substrate, in con- 
trast to the lipid emulsion used above, does not form 
interfaces. Also using this substrate, the Ser-423 mutants 
were shown not to have any significant activity com- 
pared with that of cells transfected with the pSVL vector 
alone (Fig. 2B). 
These results strongly suggest that Ser-423 is the active 
site serine of HSL. The fact that the Ser-423 mutants 
were devoid of both lipase and esterase activity rules out 
the possibility that Ser-423 is part of an interfacial bind- 
ing site rather than the catalytic site. This is also in 
agreement with what has been found for the serine of the 
GXSXG motif of the other mammalian lipases [13-181. 
Much has been learnt regarding the catalytic site of 
lipases from the determination of the three-dimensional 
structure of pancreatic lipase [ 181 and several microbial 
lipases, such as the Rhizomucor miehi lipase [28] and the 
Geotrichum candidum lipase [29]. The three-dimensional 
structure of these lipases have shown that the serine of 
the GXSXG motif is part of a catalytic triad, including 
W.T.HSL 423~SG 423~SA 423~SC 423.ST pSVL 
A DNA 
0 
W.T.HSL 423~SG 423-SA 423.SC 4 23-ST pSVL 
B DNA 
Fig. 2. Transfection of COS cells with HSL (Ser-423) mutants. 1 pg each 
of pSVL plasmids containing HSL cDNAs encoding a mutation of 
Ser-423 to Gly, Ala, Cys and Thr, respectively, were used to transfect 
COS cells, Cell homogenates were analyzed for HSL lipase activity, 
esterase activity and total protein. Shown is the HSL activity in mU/mg 
protein (A) and the esterase activity in pmolp-nitrophenol released per 
min and pug protein (B). The bars represent the mean f S.D. from three 
60 mm plates for each construct. None of the mutants were significantly 
different from pSVL alone (P > 0.01) by Student’s t-test. The different 
mutations are denoted as in Fig. 1. 
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W.T.HSL 165SA 320.SA 412.SA 533~SA pSVL 
DNA 
Fig. 3. Transfection of COS cells with HSL cDNAs encoding mutations 
in some conserved serine residues. pSVL plasmids (1 &dish) contain- 
ing HSL cDNAs encoding mutations of Ser-185 to Ala, Ser-320 to Ala, 
Ser-412 to Ala and Ser-533 to Ala, Gly, Cys or Thr, respectively, were 
used to transfect COS cells. Cell homogenates were analyzed for HSL 
lipase activity and total protein. Shown is the HSL activity in mU/mg 
protein. The bars represent the mean f S.D. from three 60 mm plates 
for each construct. None of the mutants were significantly different 
(P > 0.05) from wild-type HSL by Student’s t-test. The different muta- 
tions are denoted as in Fig. 1B. 
also an aspartic acid, or in the case of Geotrichum can- 
didum lipase a glutamic acid, and a histidine. In all these 
three lipases the catalytic triad, situated in a pocket, is 
covered by one or two surface loops or lids. Co-crystalli- 
zation experiments with inhibitors and cofactors have 
shown for both Rhizomucor miehi lipase and human pan- 
creatic lipase that during interfacial activation the lid is 
displaced, uncovering the catalytic site, and inducing 
other conformational rearrangements that create a hy- 
drophobic binding site for the substrate as well as the 
oxyanion hole [30,31]. Since the catalytic triad of pancre- 
atic lipase is known, it has been possible, by sequence 
analogy, to assign the active site aspartic acid and histid- 
ine of lipoprotein lipase [16]. However, in contrast to the 
active site serine, there is no strong consensus sequence 
environment for the active site aspartic acid or histidine, 
making it difficult to identify these residues in lipases 
lacking sequence identity to lipases with known three- 
dimensional structures. 
Since the GXSXG motif is found in virtually all micro- 
bial and mammalian lipases/esterases with known pri- 
mary structures, it is reasonable to assume that the 
GXSXG motif of these proteins is derived from a com- 
mon ancestral gene. In this context, it can be noted that 
different functional regions of HSL are encoded by dif- 
ferent exons. The GXSXG motif is encoded by exon 6, 
the regulatory phosphorylation site by exon 8 and a 
putative lipid binding site by exon 9, thus suggesting that 
HSL is a mosaic protein [5]. The GXSXG motif is also 
found around the active site serine of serine proteases. 
However, it has been shown for serine proteases of the 
chymotrypsin and subtilisin family that the structure 
around the GXSXG motif is very different from that of 
the lipases, and therefore they may not be related except 
by convergent evolution [12]. The glycines of the motif 
appear to be invariant in the lipases due to packing 
considerations and not due to restraints imposed by sec- 
ondary structure, which is the case in the chymotrypsin 
and subtilisin family. Furthermore, the serine of the 
motif adopts the very unusual r-type conformation in the 
lipases, which is not the case in the proteases [12], and 
the internal order between the residues of the catalytic 
triad is different between the lipases and serine proteases. 
A recently described family of serine proteases, the prolyl 
oligopeptidase family, however, has been suggested to be 
related to the lipases, based on the finding that they seem 
to have the catalytic residues in the same order as the 
lipases, and thus the reverse order of what is found in the 
chymotrypsin and subtilisin family [32]. 
In summary, we have used mutagenesis experiments to 
show that Ser-423 of rat HSL is the active site serine. 
This is the first demonstration in HSL of a relationship 
between catalytic function and structure. Future experi- 
ments solving the three-dimensional structure of HSL 
and more mutagenesis experiments will allow a more 
detailed description of the active site and the regions 
important for interaction with the lipid substrate. 
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